279 related articles for article (PubMed ID: 36036910)
1. Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome.
Chang CJ; Somohano K; Zemsky C; Uhlemann AC; Liebmann J; Cioffi GA; Al-Aswad LA; Lynch SV; Winn BJ
Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):32. PubMed ID: 36036910
[TBL] [Abstract][Full Text] [Related]
2. Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs.
Castro C; Marta A; Marques JH; Ferreira A; José D; Sousa P; Neves I; Menéres MJ; Barbosa I
J Glaucoma; 2023 Oct; 32(10):e113-e120. PubMed ID: 37523629
[TBL] [Abstract][Full Text] [Related]
3. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye.
Wong ABC; Wang MTM; Liu K; Prime ZJ; Danesh-Meyer HV; Craig JP
Ocul Surf; 2018 Jul; 16(3):289-293. PubMed ID: 29510226
[TBL] [Abstract][Full Text] [Related]
4. Topical glaucoma medications - Clinical implications for the ocular surface.
Fineide F; Lagali N; Adil MY; Arita R; Kolko M; Vehof J; Utheim TP
Ocul Surf; 2022 Oct; 26():19-49. PubMed ID: 35921942
[TBL] [Abstract][Full Text] [Related]
5. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma.
Lee SM; Lee JE; Kim SI; Jung JH; Shin J
Indian J Ophthalmol; 2019 Aug; 67(8):1297-1302. PubMed ID: 31332113
[TBL] [Abstract][Full Text] [Related]
7. [Ocular surface in glaucoma patients with topical treatment].
Zemba M; Papadatu CA; Enache VE; Sârbu LN
Oftalmologia; 2011; 55(3):94-8. PubMed ID: 22428298
[TBL] [Abstract][Full Text] [Related]
8. Validation of 16S rRNA Gene Sequencing of the Periocular Microbiome and Lack of Alteration by Topical Eyedrops.
Priluck A; Ramulu P; Dosto N; Quigley H; Abraham A
Transl Vis Sci Technol; 2023 Feb; 12(2):32. PubMed ID: 36826842
[TBL] [Abstract][Full Text] [Related]
9. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication.
Wong TT; Zhou L; Li J; Tong L; Zhao SZ; Li XR; Yu SJ; Koh SK; Beuerman RW
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7385-91. PubMed ID: 21697136
[TBL] [Abstract][Full Text] [Related]
11. Significantly different results in the ocular surface microbiome detected by tear paper and conjunctival swab.
Chen Z; Xiang Z; Cui L; Qin X; Chen S; Jin H; Zou H
BMC Microbiol; 2023 Jan; 23(1):31. PubMed ID: 36707800
[TBL] [Abstract][Full Text] [Related]
12. THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and.
Janderová M; Filouš A; Hložánek M; Dotřelová D; Mahelková G
Cesk Slov Oftalmol; 2021; 77(1):28-34. PubMed ID: 33740865
[TBL] [Abstract][Full Text] [Related]
13. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface microbiota in patients with aqueous tear-deficient dry eye.
Andersson J; Vogt JK; Dalgaard MD; Pedersen O; Holmgaard K; Heegaard S
Ocul Surf; 2021 Jan; 19():210-217. PubMed ID: 32931939
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review.
Nijm LM; De Benito-Llopis L; Rossi GC; Vajaranant TS; Coroneo MT
Asia Pac J Ophthalmol (Phila); 2020 Dec; 9(6):481-490. PubMed ID: 33323704
[TBL] [Abstract][Full Text] [Related]
16. Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma.
Agnifili L; Brescia L; Scatena B; Oddone F; Figus M; Perna F; Doronzo E; D'Ugo E; Mastropasqua L
J Glaucoma; 2020 May; 29(5):374-380. PubMed ID: 32079993
[TBL] [Abstract][Full Text] [Related]
17. Disturbances in the ocular surface microbiome by perioperative antimicrobial eye drops.
Hotta F; Eguchi H; Kuwahara T; Nakayama-Imaohji H; Shimomura Y; Kusaka S
Front Cell Infect Microbiol; 2023; 13():1172345. PubMed ID: 37124044
[TBL] [Abstract][Full Text] [Related]
18. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of tear meniscus using a spectral domain optical coherence tomography in medically controlled glaucoma.
Dutta P; Kalita P; Bardoloi N
Indian J Ophthalmol; 2023 Jul; 71(7):2704-2710. PubMed ID: 37417108
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls.
Mravec Bencurova D; Vyborny P; Dankova P
Int Ophthalmol; 2023 Oct; 43(10):3559-3568. PubMed ID: 37318666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
